NYSEMKT: LCTXLineage Cell Therapeutics Inc Stock Ownership - Who owns Lineage Cell Therapeutics?
Insider buying vs selling
Have Lineage Cell Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| George A. Samuel Iii | General Counsel | 2025-02-11 | 2,440 | $0.65 | $1.59kSell |
| Brian M. Culley | President and CEO | 2025-02-11 | 12,547 | $0.65 | $8.16kSell |
| Broadwood Partners LP | Director | 2025-01-27 | 7,894,737 | $0.76 | $6.00MBuy |
| Jill Ann Howe | Chief Financial Officer | 2024-11-26 | 15,000 | $0.59 | $8.85kBuy |
| George A. Samuel Iii | General Counsel | 2024-11-26 | 15,000 | $0.60 | $9.00kBuy |
| Michael H. Mulroy | Director | 2024-11-22 | 40,000 | $0.57 | $22.64kBuy |
| Brian M. Culley | President and CEO | 2024-11-21 | 40,000 | $0.60 | $24.00kBuy |
LCTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LCTX insiders and whales buy or sell their stock.
LCTX Shareholders
What type of owners hold Lineage Cell Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Broadwood Partners LP | 35.70% | 81,531,259 | $97.84M | Insider |
| Broadwood Capital Inc | 21.70% | 49,560,992 | $59.47M | Institution |
| Neal C. Bradsher | 20.81% | 47,515,269 | $57.02M | Insider |
| Alfred D. Kingsley | 4.53% | 10,344,637 | $12.41M | Insider |
| Vanguard Group Inc | 3.71% | 8,482,873 | $10.18M | Institution |
| Defender Capital LLC | 2.97% | 6,785,177 | $8.14M | Institution |
| Raffles Associates LP | 2.36% | 5,392,088 | $6.47M | Institution |
| George Karfunkel | 2.18% | 4,982,217 | $5.98M | Insider |
| Comerica Bank | 2.01% | 4,600,000 | $5.52M | Institution |
| Millennium Management LLC | 1.14% | 2,600,577 | $3.12M | Institution |
LCTX vs Biotech Stocks
Lineage Cell Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.